Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Filson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Urology|August 23, 2016
Editorial CommentChristopher Filson
Computational and Mathematical Methods in Medicine|May 6, 2014
Logic regression for provider effects on kidney cancer treatment deliveryMousumi Banerjee, Christopher Filson, Rong Xia, et al.
Urologic Oncology|December 14, 2020
Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancerYu Liu, Ingrid J Hall, Christopher Filson, et al.
Preventing Chronic Disease|April 22, 2018
Association Between Online Information-Seeking and Adherence to Guidelines for Breast and Prostate Cancer ScreeningHankyul Kim, Christopher Filson, Peter Joski, et al.
The Journal of Urology|January 20, 2026
Vasectomy and the Risk of Prostate CancerPeter N Schlegel, Sarah C Vij, Christopher Filson, et al.
World Journal of Urology|November 1, 2024
Exposure to the herbicide 2,4-dichlorophenoxyacetic acid and prostate cancer among U.S. adult menFrank Glover, Michael Eisenberg, Francesco Del Giudice, et al.
Cancer|July 6, 2016
Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008Nicholas Donin, Christopher Filson, Alexandra Drakaki, et al.
World Journal of Urology|March 27, 2021
Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsyRebecca S Steinberg, Lauren Kipling, K C Biebighauser Bens, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Urology|August 23, 2016
Editorial CommentChristopher Filson
Computational and Mathematical Methods in Medicine|May 6, 2014
Logic regression for provider effects on kidney cancer treatment deliveryMousumi Banerjee, Christopher Filson, Rong Xia, et al.
Urologic Oncology|December 14, 2020
Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancerYu Liu, Ingrid J Hall, Christopher Filson, et al.
Preventing Chronic Disease|April 22, 2018
Association Between Online Information-Seeking and Adherence to Guidelines for Breast and Prostate Cancer ScreeningHankyul Kim, Christopher Filson, Peter Joski, et al.
The Journal of Urology|January 20, 2026
Vasectomy and the Risk of Prostate CancerPeter N Schlegel, Sarah C Vij, Christopher Filson, et al.
World Journal of Urology|November 1, 2024
Exposure to the herbicide 2,4-dichlorophenoxyacetic acid and prostate cancer among U.S. adult menFrank Glover, Michael Eisenberg, Francesco Del Giudice, et al.
Cancer|July 6, 2016
Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008Nicholas Donin, Christopher Filson, Alexandra Drakaki, et al.
World Journal of Urology|March 27, 2021
Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsyRebecca S Steinberg, Lauren Kipling, K C Biebighauser Bens, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
Pageof 2